Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
IQ-AI ( (GB:IBAI) ) has issued an update.
Imaging Biometrics Limited has acquired 86.11% of Kirkstall Limited from Truetide plc, with plans to eventually own 100%. Kirkstall’s Quasi Vivo™ system, which simulates human organ interactions, is gaining traction beyond UK universities, with the US market as a key target. The acquisition, valued at £170,000, involves a convertible loan note issued to Truetide. This strategic move is expected to bolster Kirkstall’s growth, leveraging IBAI’s market expertise, and underscores IBAI’s commitment to transparent corporate governance.
More about IQ-AI
Imaging Biometrics Limited (IBAI) operates in the biotechnology industry, focusing on advanced imaging solutions. The company is known for its innovative technologies that enhance the precision of medical imaging, catering primarily to academic researchers and the drug development sector.
Average Trading Volume: 1,927,114
Technical Sentiment Signal: Sell
Current Market Cap: £2.84M
For detailed information about IBAI stock, go to TipRanks’ Stock Analysis page.